Search results for “Transplant rejection” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 4,021 patents, we discovered top 441 key players by total patent application. Bristol Myers Squibb Co., Novartis AG, Arena Pharmaceuticals, Inc. are dominant in this area. They take 16.91% of the total patent filing.
New York, United States
Patent: 252
Basel-Stadt, Switzerland
Patent: 248
California, United States
Patent: 180
Belgium
Patent: 170
New Jersey, United States
Patent: 115
New Jersey, United States
Patent: 108
Maharashtra, India
Patent: 85
Switzerland
Patent: 77
Hessen, Germany
Patent: 65
Cambridgeshire, United Kingdom
Patent: 61
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 77 patents, we discovered top 10 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, CoImmune, Inc., Myway Genetics Srl are active in this area.
STARTUP
France
Patent: 60
STARTUP
North Carolina, United States
Patent: 6
STARTUP
Myway Genetics Srl
Lombardia, Italy
Patent: 3
STARTUP
Michigan, United States
Patent: 2
STARTUP
Otago, New Zealand
Patent: 2
STARTUP
Texas, United States
Patent: 2
STARTUP
California, United States
Patent: 1
STARTUP
France
Patent: 1
STARTUP
South Korea
Patent: 1
STARTUP
AbolerIS Pharma
France
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 686 patents applied in the last 5 years. We discover 181 most active companies in this area. The fast-growing Bristol Myers Squibb Co., Galapagos NV, Arena Pharmaceuticals, Inc. take 24.78% of patent filing during this period.
New York, United States
Patent: 101
Belgium
Patent: 43
California, United States
Patent: 26
California, United States
Patent: 18
STARTUP
France
Patent: 18
Vaud, Switzerland
Patent: 16
California, United States
Patent: 14
California, United States
Patent: 13
Illinois, United States
Patent: 12
Georgia, United States
Patent: 11
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 686 patents in last 5 years, we discover 106 new entrants. Tonix Pharma Ltd., TAI Diagnostics, Inc., The Abraham J. & Phyllis Katz Cord Blood Foundation are the most active new entrants in this area.
DUBLIN, Ireland
Patent: 9
Wisconsin, United States
Patent: 8
Ohio, United States
Patent: 7
North Carolina, United States
Patent: 6
Rappta Therapeutics Oy
Finland
Patent: 6
Shanghai Shi, China
Patent: 6
Shanghai Shi, China
Patent: 6
South Korea
Patent: 6
Guangdong Sheng, China
Patent: 6
South Korea
Patent: 5
Research Institutions
Order by:
Innovation Intensity
With the analysis among 1,048 patents, we discovered top 108 universities and scientific research institutions by total patent application. Emory University, The Johns Hopkins University, École Polytechnique Fédérale de Lausanne are dominant in this area. They take 15.84% of the total patent filing.
Georgia, United States
Patent: 49
United States
Patent: 45
Vaud, Switzerland
Patent: 40
California, United States
Patent: 40
Illinois, United States
Patent: 34
New Hampshire, United States
Patent: 24
British Columbia, Canada
Patent: 22
New York, United States
Patent: 17
Connecticut, United States
Patent: 17
Illinois, United States
Patent: 15
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: